BACKGROUND: Few epidemiologic studies have examined very high intakes of folate and whether consumption of nutrients involved in one-carbon metabolism is associated with breast cancer risk. OBJECTIVE: We prospectively examined whether the consumption of folate and nutrients involved in one-carbon metabolism (methionine, riboflavin, and vitamins B-6 and B-12) from self-reported intakes of diet (in year before baseline) and supplements (averaged over 10 y before baseline) were associated with the incidence of breast cancer and breast cancer tumor characteristics. DESIGN: Participants were 35,023 postmenopausal women aged 50-76 y in the VITamins And Lifestyle (VITAL) cohort study; breast cancer was diagnosed in 743 of these women between baseline (2000-2002) and 2006. Cox proportional hazards models were used to estimate multivariable-adjusted relative risks (RRs) and 95% CIs. RESULTS: Women consuming > or =1272 dietary folate equivalents (DFE)/d of total folate (10-y average) had a 22% decrease in breast cancer risk compared with women consuming < or =345 DFE/d (RR: 0.78; 95% CI: 0.61, 0.99; P for trend = 0.05). A greater benefit was observed for estrogen-receptor (ER) negative than for ER+ breast cancers (RR: 0.38; 95% CI: 0.18, 0.80; P for trend = 0.02; P = 0.02 for the difference between ER- and ER+). Neither current intakes of folate nor current or long-term intakes of other one-carbon nutrients were significantly associated with breast cancer risk. Multivitamin use attenuated the increased risk of breast cancer associated with alcohol drinking (P for interaction = 0.02). CONCLUSIONS: Our study of predominantly supplement users suggests that high intakes of folate averaged over 10 y do not increase breast cancer risk, but may be protective, particularly against ER- breast cancers.
BACKGROUND: Few epidemiologic studies have examined very high intakes of folate and whether consumption of nutrients involved in one-carbon metabolism is associated with breast cancer risk. OBJECTIVE: We prospectively examined whether the consumption of folate and nutrients involved in one-carbon metabolism (methionine, riboflavin, and vitamins B-6 and B-12) from self-reported intakes of diet (in year before baseline) and supplements (averaged over 10 y before baseline) were associated with the incidence of breast cancer and breast cancer tumor characteristics. DESIGN:Participants were 35,023 postmenopausal women aged 50-76 y in the VITamins And Lifestyle (VITAL) cohort study; breast cancer was diagnosed in 743 of these women between baseline (2000-2002) and 2006. Cox proportional hazards models were used to estimate multivariable-adjusted relative risks (RRs) and 95% CIs. RESULTS:Women consuming > or =1272 dietary folate equivalents (DFE)/d of total folate (10-y average) had a 22% decrease in breast cancer risk compared with women consuming < or =345 DFE/d (RR: 0.78; 95% CI: 0.61, 0.99; P for trend = 0.05). A greater benefit was observed for estrogen-receptor (ER) negative than for ER+ breast cancers (RR: 0.38; 95% CI: 0.18, 0.80; P for trend = 0.02; P = 0.02 for the difference between ER- and ER+). Neither current intakes of folate nor current or long-term intakes of other one-carbon nutrients were significantly associated with breast cancer risk. Multivitamin use attenuated the increased risk of breast cancer associated with alcohol drinking (P for interaction = 0.02). CONCLUSIONS: Our study of predominantly supplement users suggests that high intakes of folate averaged over 10 y do not increase breast cancer risk, but may be protective, particularly against ER- breast cancers.
Authors: Shumin M Zhang; I-Min Lee; JoAnn E Manson; Nancy R Cook; Walter C Willett; Julie E Buring Journal: Am J Epidemiol Date: 2007-01-04 Impact factor: 4.897
Authors: T A Sellers; L H Kushi; J R Cerhan; R A Vierkant; S M Gapstur; C M Vachon; J E Olson; T M Therneau; A R Folsom Journal: Epidemiology Date: 2001-07 Impact factor: 4.822
Authors: Joanne Kotsopoulos; Alan Medline; Richard Renlund; Kyoung-Jin Sohn; Rochelle Martin; Stephen W Hwang; Suying Lu; Michael C Archer; Young-In Kim Journal: Carcinogenesis Date: 2005-05-11 Impact factor: 4.944
Authors: S Zhang; D J Hunter; S E Hankinson; E L Giovannucci; B A Rosner; G A Colditz; F E Speizer; W C Willett Journal: JAMA Date: 1999-05-05 Impact factor: 56.272
Authors: Thomas A Sellers; Dawn M Grabrick; Robert A Vierkant; Lisa Harnack; Janet E Olson; Celine M Vachon; James R Cerhan Journal: Cancer Causes Control Date: 2004-03 Impact factor: 2.506
Authors: Zhihong Gong; Christine B Ambrosone; Susan E McCann; Gary Zirpoli; Urmila Chandran; Chi-Chen Hong; Dana H Bovbjerg; Lina Jandorf; Gregory Ciupak; Karen Pawlish; Quanjun Lu; Helena Hwang; Thaer Khoury; Bshara Wiam; Elisa V Bandera Journal: Int J Cancer Date: 2013-09-30 Impact factor: 7.396
Authors: Galina Lurie; Lynne R Wilkens; Yurii B Shvetsov; Nicholas J Ollberding; Adrian A Franke; Brian E Henderson; Laurence N Kolonel; Marc T Goodman Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-08-09 Impact factor: 4.254
Authors: Yuan Ji; Kendra K S Nordgren; Yubo Chai; Scott J Hebbring; Gregory D Jenkins; Ryan P Abo; Yi Peng; Linda L Pelleymounter; Irene Moon; Bruce W Eckloff; Xiaoshan Chai; Jianping Zhang; Brooke L Fridley; Vivien C Yee; Eric D Wieben; Richard M Weinshilboum Journal: Drug Metab Dispos Date: 2012-07-17 Impact factor: 3.922
Authors: Seungyoun Jung; Molin Wang; Kristin Anderson; Laura Baglietto; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Louise Brinton; Julie E Buring; A Heather Eliassen; Roni Falk; Susan M Gapstur; Graham G Giles; Gary Goodman; Judith Hoffman-Bolton; Pamela L Horn-Ross; Manami Inoue; Laurence N Kolonel; Vittorio Krogh; Marie Lof; Paige Maas; Anthony B Miller; Marian L Neuhouser; Yikyung Park; Kim Robien; Thomas E Rohan; Stephanie Scarmo; Leo J Schouten; Sabina Sieri; Victoria L Stevens; Schoichiro Tsugane; Kala Visvanathan; Lynne R Wilkens; Alicja Wolk; Elisabete Weiderpass; Walter C Willett; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Xuehong Zhang; Regina G Ziegler; Stephanie A Smith-Warner Journal: Int J Epidemiol Date: 2015-08-28 Impact factor: 7.196